Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)
      QxMD      Google Scholar   
Citation:
Breast Cancer Res Treat vol 161 (2) 363-373
Year:
2017
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
6
Parents:
None
Children:
None
Program:
CCP
Primary Committee:
Older Adult
Sec. Committees:
Breast    
Pharmas:
 
Grants:
UG1CA189823, U10CA032291, U10CA047559, U10CA047577, U10CA077597, U10CA077651, U10CA180790, U10CA180791, U10CA180838, U10CA180857, U10CA180867, U10 CA047577, U10 CA032291, P30 CA016672, P30 CA016086, U10 CA077597, U10 CA180791, U10 CA180857, UG1 CA189823, U10 CA047559, U10 CA077651, U10 CA180790, U10 CA180867, U10 CA180838  
Corr. Author:
 
Authors:
                                         
Networks:
LAPS-CT018, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NC010, LAPS-NY016, LAPS-TX035, NC002, NORTHWELL   
Study
Alliance-A151511
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-40101, CALGB-49907, CALGB-9344, CALGB-9741
Phases:
N/A, 3
Keywords:
Breast cancer, Older patients, Leukemia, Myelodysplastic syndrome, Chemotherapy